Down-regulation of cell surface CXCR4 by HIV-1

[1]  John P. Moore,et al.  HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry. , 2007, Virology.

[2]  Tracy M Handel,et al.  Chemokine: receptor structure, interactions, and antagonism. , 2007, Annual review of immunology.

[3]  O. W. Lindwasser,et al.  Mechanisms of CD4 downregulation by the Nef and Vpu proteins of primate immunodeficiency viruses. , 2007, Current molecular medicine.

[4]  O. W. Lindwasser,et al.  Downregulation of CD4 by Human Immunodeficiency Virus Type 1 Nef Is Dependent on Clathrin and Involves Direct Interaction of Nef with the AP2 Clathrin Adaptor , 2007, Journal of Virology.

[5]  Oliver T. Fackler,et al.  Expression of Nef Downregulates CXCR4, the Major Coreceptor of Human Immunodeficiency Virus, from the Surfaces of Target Cells and Thereby Enhances Resistance to Superinfection , 2006, Journal of Virology.

[6]  B. Berkhout,et al.  Retroviral superinfection resistance , 2005, Retrovirology.

[7]  Oliver T. Fackler,et al.  The Nef Protein of Human Immunodeficiency Virus Establishes Superinfection Immunity by a Dual Strategy to Downregulate Cell-Surface CCR5 and CD4 , 2005, Current Biology.

[8]  W. Greene,et al.  Human Immunodeficiency Virus Type 1 Nef-Mediated Downregulation of CD4 Correlates with Nef Enhancement of Viral Pathogenesis , 2003, Journal of Virology.

[9]  Osamu Yoshie,et al.  Chemokine/chemokine receptor nomenclature. , 2003, Cytokine.

[10]  T. Hope,et al.  Association of Chemokine-mediated Block to HIV Entry with Coreceptor Internalization* , 2002, The Journal of Biological Chemistry.

[11]  Hermann Bujard,et al.  Studying gene function in eukaryotes by conditional gene inactivation. , 2002, Annual review of genetics.

[12]  P. Murphy.  Viral exploitation and subversion of the immune system through chemokine mimicry , 2001, Nature Immunology.

[13]  A. Trkola,et al.  Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140 , 2001, Journal of Virology.

[14]  P. Briand,et al.  CXCR4 Is Down-Regulated in Cells Infected with the CD4-Independent X4 Human Immunodeficiency Virus Type 1 Isolate m7NDK , 2001, Journal of Virology.

[15]  P. Gray,et al.  Co‐receptor use by HIV and inhibition of HIV infection by chemokine receptor ligands , 2000, Immunological reviews.

[16]  C. Broder,et al.  Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by beta-chemokines (RANTES) in primary human macrophages. , 2000, The Journal of infectious diseases.

[17]  Q. Sattentau,et al.  Selective HIV-1-induced downmodulation of CD4 and coreceptors , 2000, Archives of Virology.

[18]  R. Doms,et al.  CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999, Blood.

[19]  A. Hasegawa,et al.  Down-regulation of CXCR4 by human herpesvirus 6 (HHV-6) and HHV-7. , 1999, Journal of immunology.

[20]  S. Rhee,et al.  HIV-1 Nef plays an essential role in two independent processes in CD4 down-regulation: dissociation of the CD4-p56(lck) complex and targeting of CD4 to lysosomes. , 1999, Virology.

[21]  G. Simmons,et al.  HIV coreceptors, cell tropism and inhibition by chemokine receptor ligands. , 1999, Molecular membrane biology.

[22]  J. Farber,et al.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.

[23]  F. Ruscetti,et al.  Inhibition of the expression and function of chemokine receptors on human CD4+ leukocytes by HIV-1 envelope protein gp120. , 1999, Chemical immunology.

[24]  R. Doms,et al.  CD4-independent utilization of the CXCR4 chemokine receptor by HIV-1 and HIV-2. , 1998, Journal of reproductive immunology.

[25]  C. Broder,et al.  HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation. , 1998, Journal of immunology.

[26]  M. Kavanaugh,et al.  gp120 envelope glycoproteins of human immunodeficiency viruses competitively antagonize signaling by coreceptors CXCR4 and CCR5. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[27]  O. Turriziani,et al.  Inhibition of HIV Type 1 BaL Replication by MIP-lα, MIP-1β, and RANTES in Macrophages , 1998 .

[28]  Potash,et al.  Viral interference in HIV-1 infected cells. , 1998, Reviews in medical virology.

[29]  O. Turriziani,et al.  Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages. , 1998, AIDS research and human retroviruses.

[30]  J. Albert,et al.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype , 1997, Journal of virology.

[31]  Q. Sattentau,et al.  HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4. , 1997, Journal of immunology.

[32]  B. Cullen,et al.  Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor , 1997, The EMBO journal.

[33]  Jean Salamero,et al.  HIV Coreceptor Downregulation as Antiviral Principle: SDF-1α–dependent Internalization of the Chemokine Receptor CXCR4 Contributes to Inhibition of HIV Replication , 1997, The Journal of experimental medicine.

[34]  T. Schwartz,et al.  Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist. , 1997, Science.

[35]  J. Moore.  Coreceptors--Implications for HIV Pathogenesis and Therapy , 1997, Science.

[36]  J. Silver,et al.  Rapid degradation of CD4 in cells expressing human immunodeficiency virus type 1 Env and Vpu is blocked by proteasome inhibitors. , 1997, The Journal of general virology.

[37]  J. Sodroski,et al.  CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia , 1997, Nature.

[38]  B Dewald,et al.  Human chemokines: an update. , 1997, Annual review of immunology.

[39]  J. Albert,et al.  Sensitivity to inhibition by beta-chemokines correlates with biological phenotypes of primary HIV-1 isolates. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[40]  R. Doms,et al.  CD4-Independent Infection by HIV-2 Is Mediated by Fusin/CXCR4 , 1996, Cell.

[41]  William C. Olson,et al.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5 , 1996, Nature.

[42]  D. Dimitrov,et al.  Evidence for Cell-Surface Association Between Fusin and the CD4-gp120 Complex in Human Cell Lines , 1996, Science.

[43]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[44]  T. Oravecz,et al.  Beta-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step. , 1996, Journal of immunology.

[45]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[46]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[47]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[48]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[49]  G Vassart,et al.  Molecular cloning and functional expression of a new human CC-chemokine receptor gene. , 1996, Biochemistry.

[50]  J. Sodroski,et al.  Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1 , 1996, Journal of virology.

[51]  C. Broder,et al.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. , 1996, Science.

[52]  M. Wainberg,et al.  HIV‐1 associated down‐modulation of CD4 gene expression is differentially restricted in lymphocytic and monocytic cell lines , 1994, Journal of Leukocyte Biology.

[53]  M. Martin,et al.  Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4 , 1992, Journal of virology.

[54]  M. Ferrer,et al.  Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. , 1992, Journal of immunology.

[55]  B. Crise,et al.  Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum , 1992, Journal of virology.

[56]  M. Wainberg,et al.  Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1 , 1991, Journal of virology.

[57]  J. Garcia,et al.  Serine phosphorylation-independent downregulation of cell-surface CD4 by nef , 1991, Nature.

[58]  B. Crise,et al.  CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor , 1990, Journal of virology.

[59]  M. Kieny,et al.  Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication , 1988, The Journal of experimental medicine.

[60]  H. Temin.  Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses. , 1988, Reviews of infectious diseases.

[61]  J. Hoxie,et al.  T4 endocytosis and phosphorylation induced by phorbol esters but not by mitogen or HIV infection. , 1988, Journal of immunology.

[62]  J. Hoxie,et al.  Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. , 1986, Science.

[63]  H. Temin,et al.  Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus , 1980, Journal of virology.

[64]  P. Vogt,et al.  Patterns of viral interference in the avian leukosis and sarcoma complex. , 1966, Virology.